Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8OG0

Crystal structure of MJF14-6-4-2 Fab fragment in complex with epitope peptide

Summary for 8OG0
Entry DOI10.2210/pdb8og0/pdb
DescriptorFab fragment light chain, Fab fragment heavy chain, Alpha-synuclein, ... (4 entities in total)
Functional Keywordsalpha synuclein, fab fragment, mjf14-6-4-2, epitope, immune system
Biological sourceOryctolagus cuniculus
More
Total number of polymer chains3
Total formula weight46864.98
Authors
Tars, K.,Lieknina, I. (deposition date: 2023-03-17, release date: 2024-03-27, Last modification date: 2024-11-06)
Primary citationLieknina, I.,Reimer, L.,Pantelejevs, T.,Lends, A.,Jaudzems, K.,El-Turabi, A.,Gram, H.,Hammi, A.,Jensen, P.H.,Tars, K.
Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2.
NPJ Parkinsons Dis, 10:206-206, 2024
Cited by
PubMed Abstract: Alpha-synuclein (α-syn) inclusions in the brain are hallmarks of so-called Lewy body diseases. Lewy bodies contain mainly aggregated α-syn together with some other proteins. Monomeric α-syn lacks a well-defined three-dimensional structure, but it can aggregate into oligomeric and fibrillar amyloid species, which can be detected using specific antibodies. Here we investigate the aggregate specificity of monoclonal MJFR14-6-4-2 antibodies. We conclude that partial masking of epitope in unstructured monomer in combination with a high local concentration of epitopes is the main reason for MJFR14-6-4-2 selectivity towards aggregates. Based on the structural insight, we produced mutant α-syn that when fibrillated is unable to bind MJFR14-6-4-2. Using these fibrils as a tool for seeding cellular α-syn aggregation, provides superior signal/noise ratio for detection of cellular α-syn aggregates by MJFR14-6-4-2. Our data provide a molecular level understanding of specific recognition of toxic amyloid oligomers, which is critical for the development of inhibitors against synucleinopathies.
PubMed: 39463404
DOI: 10.1038/s41531-024-00822-y
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.712 Å)
Structure validation

238268

数据于2025-07-02公开中

PDB statisticsPDBj update infoContact PDBjnumon